| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6109594 | Journal of Hepatology | 2009 | 7 Pages |
Abstract
In conclusion, in patients with cirrhosis due to HBeAg-negative CHB, lamivudine monotherapy reduces HVPG, especially when virological suppression and biochemical remission is achieved.
Keywords
CHBVBRBBRWHVPFHVPHVPGALTSBPHCCASTAlanine aminotransaminaseHepatic venous pressure gradientfree hepatic venous pressurewedged hepatic venous pressurePortal pressureLAMLamivudineModel for End-Stage Liver Diseasechronic hepatitis Bpolymerase chain reactionPCRspontaneous bacterial peritonitisprognosisHepatocellular carcinomaChild-PughMELD
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Spilios Manolakopoulos, Christos Triantos, Jiannis Theodoropoulos, Jiannis Vlachogiannakos, Anastasios Kougioumtzan, George Papatheodoridis, Dimitrios Tzourmakliotis, Dimitrios Karamanolis, Andrew K. Burroughs, Athanasios Archimandritis, Sotirios Raptis,